The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Focused Issues

심혈관질환과 SGLT2억제제: 박진주; J Korean Diabetes. 2024;25(1):26-34. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.26

만성콩팥병과 SGLT2억제제: 고은실, 정성진; J Korean Diabetes. 2024;25(1):16-25. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.16

당뇨병과 SGLT2억제제: 지금까지의 여정과 향후 과제: 김지윤, 김신곤; J Korean Diabetes. 2024;25(1):9-15. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.9

Information Desks

최신 당뇨병 치료제의 특징: 윤누리; J Korean Diabetes. 2023;24(3):148-153. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.148

Focused Issues

Sodium Glucose Cotransporter-2 억제제의 최신지견: 조동혁; J Korean Diabetes. 2021;22(2):113-125. Published online June 30, 2021; DOI: https://doi.org/10.4093/jkd.2021.22.2.113

Guideline

제2형 당뇨병 환자에서 장기간의 Sodium-Glucose Cotransporter 2 억제제 치료가 신장기능에 미치는 효과: 백종하, 오태정, 문주영, 김태희, 고승현, 문민경, 김현정, 이동원, 허규연, 대한당뇨병학회 진료지침위원회, 대한신장학회 협연위원회; J Korean Diabetes. 2020;21(3):105-115. Published online September 30, 2020; DOI: https://doi.org/10.4093/jkd.2020.21.3.105

Opinion

Sodium-Glucose Cotransporter 2 Inhibitor의 안전성: 임상에서 고려해야 할 점: Soo Lim; J Korean Diabetes. 2019;20(3):127-135. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.127

Focused Issues

제1형 당뇨병 환자에서 Sodium-Glucose Cotransporter 2 억제제 사용: Choong Hee Kim, Jun Sung Moon; J Korean Diabetes. 2019;20(2):92-98. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.92

Sodium-Glucose Cotransporter 2 억제제의 심혈관 질환 예방 효과 유발 기전: Jae Han Jeon; J Korean Diabetes. 2019;20(2):81-86. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.81

Sodium-Glucose Cotransporter 2 억제제의 작용 기전 및 다양한 효과: Kyung Soo Kim; J Korean Diabetes. 2019;20(2):74-80. Published online July 17, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.2.74
Cited By 1

Opinion

관찰연구에서 확인된 SGLT2 억제제의 심혈관질환 예방효과: 한국인의 결과를 중심으로: Kyoung Hwa Ha, Dae Jung Kim; J Korean Diabetes. 2018;19(3):135-139. Published online October 5, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.3.135

Focused Issues

혈당강하제를 통한 지방간 치료: Hyekyung Yang, Cheol Young Park; J Korean Diabetes. 2018;19(2):88-96. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.88
Cited By 1

Opinion

2018년 미국당뇨병학회 진료지침 속의 작지만 큰 변화: Jeong Hyun Park; J Korean Diabetes. 2018;19(2):71-75. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.71
Cited By 1

Original Article

당뇨병 환자에서 Dapagliflozin 투여 전후의 혈당변화: 단일 기관 신약 안전성 모니터 결과: Hyung Woo Lee, Sun Joon Moon, Hee Sim Han, Eun Jeong Shin, Jin Hee Baek, Hyun Joo Han, Young Min Cho, Kwi Suk Kim; J Korean Diabetes. 2017;18(4):275-283. Published online January 10, 2018; DOI: https://doi.org/10.4093/jkd.2017.18.4.275

Information Desks

당뇨병 환자의 건강한 외식하기: Hae Young Lee; J Korean Diabetes. 2017;18(4):264-269. Published online January 10, 2018; DOI: https://doi.org/10.4093/jkd.2017.18.4.264
Cited By 1

Volume 25, No. 1

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

3,961	Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management
1,346	Diabetes and Dietary Fats
4,438	Recent Advances in Anti-Obesity Drugs
2,223	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
1,120	2023 Clinical Practice Guidelines for Diabetes

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2024 by Korean Diabetes Association. All rights reserved.